MHRA updates Guidance on Sourcing Medicines for the UK Market
Register now for ECA's GMP Newsletter
The UK Medicines & Healthcare Products Regulatory Agency (MHRA) has updated its guidance on sourcing medicines for the UK market.
The document, which was first published on 31 December 2020, provides information on sourcing medicines that can be supplied by holders of wholesale distributor authorisations (WDAs) based in the UK.
The guidance covers the following aspects:
- Importing authorised medicines into the UK from a source which is on the approved country for import list
- Importing human medicines from a country on the list – for use as a special medicinal product
- Procuring human medicines from a country on the list for export purposes
- Importing medicines from a country on the list for supply to the United Kingdom parallel import market
The latest updates, published on 30 December 2024, reflect the new UK-wide licensing arrangements for human medicines that came into effect from 01 January 2025 as part of the Windsor Framework.
The complete guidance is available on the MHRA website.
Related GMP News
13.02.2025USP Publishes Summary of Comments on Chapter <1079.2> Regarding Mean Kinetic Temperature (MKT)
13.02.2025First GDP Non-Compliance Report of 2025: Data Integrity Issues at Hungarian Wholesaler
16.01.2025EMA adds Considerations for Wholesale Distributors and Brokers on suspicious Offers
16.01.2025Swissmedic informs about Control Campaign against illegal Trading in Medicinal Products
16.01.2025Two new PICS Documents on Remote Assessments published